APOB and metabolic dysfunction-associated steatohepatitis: After ACCi treatment, cirrhotic NASH patients displayed elevated plasma TG levels and LDL-apoB FRR and ASR as compared to noncirrhotic subjects (Figs. 1C and 2F, I).